Home/Filings/4/0001104659-19-016364
4//SEC Filing

Cashman Christopher Michael 4

Accession 0001104659-19-016364

CIK 0001267813other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 5:57 PM ET

Size

6.7 KB

Accession

0001104659-19-016364

Insider Transaction Report

Form 4
Period: 2019-03-18
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Stock option (right to buy)

    2019-03-1831,6620 total
    Exercise: $1.04Exp: 2023-04-04Common stock (31,662 underlying)
  • Exercise/Conversion

    Common stock

    2019-03-18$1.04/sh+31,662$32,928271,423 total
Footnotes (1)
  • [F1]17,596 shares vested on 04/04/2013; remaining shares vested in 43 equal monthly installments

Documents

1 file

Issuer

MARINUS PHARMACEUTICALS INC

CIK 0001267813

Entity typeother

Related Parties

1
  • filerCIK 0001615437

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 5:57 PM ET
Size
6.7 KB